Saurin Shah, Chief Product Officer at TigerConnect
A single misrouted page in an ICU can delay treatment by hours — and cost lives. Across U.S. hospitals, those small lapses add up to billions in…
Continue Reading
What You Should Know:
– Datavant, a data collaboration platform for healthcare, has announced an agreement to acquire DigitalOwl, a company specializing in AI-driven medical data analysis. Financial details of the acquisition were not disclosed.
–…
Continue Reading
Kirsten Major, chief executive at Sheffield Teaching Hospitals NHS Foundation Trust (Credit: STH)
Patients have complained about disruption to outpatients bookings and waiting lists following the introduction of a new electronic patient record (EPR)…
Continue Reading
Dr. Peter Schoch, MD, Chief Health Officer at Kno2
Clinical information isn’t moving where it needs to go.
Despite decades of investment in health IT, the industry is still grappling with basic data exchange. As recently…
Continue Reading
Sepsis, a life-threatening disease caused by infection, presents a major global health challenge due to its high morbidity and mortality rates. A rapid and precise diagnosis of sepsis is essential for better patient outcomes….
Continue Reading
A mounting cybersecurity crisis is threatening America’s healthcare infrastructure as small and rural hospitals increasingly delay critical security improvements. According to a comprehensive June 30 report from Black Book Research, financial pressures from looming…
Continue Reading
Promise and Paradox in Cell Therapy Growth
Cell and gene therapies (CGTs) stand at the precipice of transformative growth, with Cardinal Health’s “2025 Advanced Therapies Report” projecting over 200 FDA-approved treatments and 100,000+ U.S. patients…
Josh Canavan, Head of Pharmacy at RazorMetrics
Millions of Americans are currently facing a difficult choice: either pay for expensive biologic medications or ration doses to afford basic needs. Cost-related nonadherence (CRN) is where patients…
Continue Reading
Delays in translating new medical evidence into clinical practice hinder patient access to the best available treatments. Our data reveals an average delay of nine years from the initiation of human research to its…
Continue Reading
Accurate assessment of progression and disease course in multiple sclerosis (MS) is vital for timely and appropriate clinical intervention. The gradual transition from relapsing-remitting MS (RRMS) to secondary progressive MS (SPMS) is often diagnosed…
Continue Reading
